nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Estradiol—osteoporosis	0.0583	0.111	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0583	0.111	CbGbCtD
Temsirolimus—ABCB1—Ethinyl Estradiol—osteoporosis	0.0441	0.0841	CbGbCtD
Temsirolimus—CYP3A5—Estradiol—osteoporosis	0.0437	0.0833	CbGbCtD
Temsirolimus—CYP3A4—Estropipate—osteoporosis	0.041	0.0782	CbGbCtD
Temsirolimus—CYP3A4—Calcitriol—osteoporosis	0.041	0.0782	CbGbCtD
Temsirolimus—CYP2D6—Cholecalciferol—osteoporosis	0.0332	0.0634	CbGbCtD
Temsirolimus—CYP3A4—Ergocalciferol—osteoporosis	0.0328	0.0625	CbGbCtD
Temsirolimus—ABCB1—Conjugated Estrogens—osteoporosis	0.0324	0.0617	CbGbCtD
Temsirolimus—ABCB1—Estradiol—osteoporosis	0.0284	0.0542	CbGbCtD
Temsirolimus—CYP3A4—Raloxifene—osteoporosis	0.0274	0.0522	CbGbCtD
Temsirolimus—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0264	0.0504	CbGbCtD
Temsirolimus—CYP3A4—Cholecalciferol—osteoporosis	0.0211	0.0403	CbGbCtD
Temsirolimus—CYP3A4—Conjugated Estrogens—osteoporosis	0.0194	0.037	CbGbCtD
Temsirolimus—CYP3A4—Estradiol—osteoporosis	0.017	0.0325	CbGbCtD
Temsirolimus—Skin disorder—Risedronate—osteoporosis	0.000263	0.000749	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Calcitriol—osteoporosis	0.000263	0.000749	CcSEcCtD
Temsirolimus—Abdominal pain—Raloxifene—osteoporosis	0.000263	0.000747	CcSEcCtD
Temsirolimus—Body temperature increased—Raloxifene—osteoporosis	0.000263	0.000747	CcSEcCtD
Temsirolimus—Abdominal pain—Ibandronate—osteoporosis	0.00026	0.00074	CcSEcCtD
Temsirolimus—Body temperature increased—Ibandronate—osteoporosis	0.00026	0.00074	CcSEcCtD
Temsirolimus—Leukopenia—Zoledronate—osteoporosis	0.000258	0.000735	CcSEcCtD
Temsirolimus—Anaphylactic shock—Pamidronate—osteoporosis	0.000258	0.000733	CcSEcCtD
Temsirolimus—Oedema—Pamidronate—osteoporosis	0.000258	0.000733	CcSEcCtD
Temsirolimus—Infection—Pamidronate—osteoporosis	0.000256	0.000728	CcSEcCtD
Temsirolimus—Rhinitis—Estradiol—osteoporosis	0.000256	0.000728	CcSEcCtD
Temsirolimus—Abdominal pain—Calcitriol—osteoporosis	0.000254	0.000724	CcSEcCtD
Temsirolimus—Body temperature increased—Calcitriol—osteoporosis	0.000254	0.000724	CcSEcCtD
Temsirolimus—Angioedema—Conjugated Estrogens—osteoporosis	0.000254	0.000722	CcSEcCtD
Temsirolimus—Pharyngitis—Estradiol—osteoporosis	0.000253	0.000721	CcSEcCtD
Temsirolimus—Hypersensitivity—Estropipate—osteoporosis	0.000253	0.000719	CcSEcCtD
Temsirolimus—Nervous system disorder—Pamidronate—osteoporosis	0.000253	0.000719	CcSEcCtD
Temsirolimus—Thrombocytopenia—Pamidronate—osteoporosis	0.000252	0.000718	CcSEcCtD
Temsirolimus—Urinary tract disorder—Estradiol—osteoporosis	0.000252	0.000717	CcSEcCtD
Temsirolimus—Vomiting—Etidronic acid—osteoporosis	0.000252	0.000717	CcSEcCtD
Temsirolimus—Cough—Zoledronate—osteoporosis	0.000252	0.000716	CcSEcCtD
Temsirolimus—Oedema peripheral—Estradiol—osteoporosis	0.000251	0.000716	CcSEcCtD
Temsirolimus—Connective tissue disorder—Estradiol—osteoporosis	0.000251	0.000714	CcSEcCtD
Temsirolimus—Urethral disorder—Estradiol—osteoporosis	0.00025	0.000712	CcSEcCtD
Temsirolimus—Rash—Etidronic acid—osteoporosis	0.00025	0.000711	CcSEcCtD
Temsirolimus—Convulsion—Zoledronate—osteoporosis	0.00025	0.000711	CcSEcCtD
Temsirolimus—Dermatitis—Etidronic acid—osteoporosis	0.00025	0.000711	CcSEcCtD
Temsirolimus—Hypertension—Zoledronate—osteoporosis	0.000249	0.000708	CcSEcCtD
Temsirolimus—Hypersensitivity—Alendronate—osteoporosis	0.000249	0.000708	CcSEcCtD
Temsirolimus—Headache—Etidronic acid—osteoporosis	0.000248	0.000707	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000247	0.000703	CcSEcCtD
Temsirolimus—Asthenia—Estropipate—osteoporosis	0.000246	0.0007	CcSEcCtD
Temsirolimus—Anorexia—Pamidronate—osteoporosis	0.000246	0.000699	CcSEcCtD
Temsirolimus—Arthralgia—Zoledronate—osteoporosis	0.000245	0.000699	CcSEcCtD
Temsirolimus—Chest pain—Zoledronate—osteoporosis	0.000245	0.000699	CcSEcCtD
Temsirolimus—Myalgia—Zoledronate—osteoporosis	0.000245	0.000699	CcSEcCtD
Temsirolimus—Insomnia—Risedronate—osteoporosis	0.000245	0.000698	CcSEcCtD
Temsirolimus—Anxiety—Zoledronate—osteoporosis	0.000245	0.000696	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000244	0.000694	CcSEcCtD
Temsirolimus—Pruritus—Estropipate—osteoporosis	0.000243	0.00069	CcSEcCtD
Temsirolimus—Asthenia—Alendronate—osteoporosis	0.000242	0.00069	CcSEcCtD
Temsirolimus—Hypersensitivity—Ibandronate—osteoporosis	0.000242	0.00069	CcSEcCtD
Temsirolimus—Cough—Conjugated Estrogens—osteoporosis	0.000242	0.00069	CcSEcCtD
Temsirolimus—Dyspnoea—Risedronate—osteoporosis	0.000242	0.000688	CcSEcCtD
Temsirolimus—Erythema multiforme—Estradiol—osteoporosis	0.000241	0.000687	CcSEcCtD
Temsirolimus—Convulsion—Conjugated Estrogens—osteoporosis	0.000241	0.000685	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00024	0.000683	CcSEcCtD
Temsirolimus—Fatigue—Ethinyl Estradiol—osteoporosis	0.00024	0.000682	CcSEcCtD
Temsirolimus—Pruritus—Alendronate—osteoporosis	0.000239	0.00068	CcSEcCtD
Temsirolimus—Eye disorder—Estradiol—osteoporosis	0.000239	0.000679	CcSEcCtD
Temsirolimus—Constipation—Ethinyl Estradiol—osteoporosis	0.000238	0.000676	CcSEcCtD
Temsirolimus—Hypersensitivity—Calcitriol—osteoporosis	0.000237	0.000675	CcSEcCtD
Temsirolimus—Cardiac disorder—Estradiol—osteoporosis	0.000237	0.000674	CcSEcCtD
Temsirolimus—Arthralgia—Conjugated Estrogens—osteoporosis	0.000236	0.000673	CcSEcCtD
Temsirolimus—Chest pain—Conjugated Estrogens—osteoporosis	0.000236	0.000673	CcSEcCtD
Temsirolimus—Myalgia—Conjugated Estrogens—osteoporosis	0.000236	0.000673	CcSEcCtD
Temsirolimus—Asthenia—Ibandronate—osteoporosis	0.000236	0.000671	CcSEcCtD
Temsirolimus—Anxiety—Conjugated Estrogens—osteoporosis	0.000236	0.00067	CcSEcCtD
Temsirolimus—Nausea—Etidronic acid—osteoporosis	0.000235	0.00067	CcSEcCtD
Temsirolimus—Oedema—Zoledronate—osteoporosis	0.000235	0.00067	CcSEcCtD
Temsirolimus—Anaphylactic shock—Zoledronate—osteoporosis	0.000235	0.00067	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000235	0.000668	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000235	0.000668	CcSEcCtD
Temsirolimus—Diarrhoea—Estropipate—osteoporosis	0.000235	0.000668	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Risedronate—osteoporosis	0.000234	0.000666	CcSEcCtD
Temsirolimus—Infection—Zoledronate—osteoporosis	0.000234	0.000665	CcSEcCtD
Temsirolimus—Fatigue—Risedronate—osteoporosis	0.000234	0.000665	CcSEcCtD
Temsirolimus—Insomnia—Pamidronate—osteoporosis	0.000233	0.000663	CcSEcCtD
Temsirolimus—Pruritus—Ibandronate—osteoporosis	0.000233	0.000662	CcSEcCtD
Temsirolimus—Pain—Risedronate—osteoporosis	0.000232	0.00066	CcSEcCtD
Temsirolimus—Constipation—Risedronate—osteoporosis	0.000232	0.00066	CcSEcCtD
Temsirolimus—Angiopathy—Estradiol—osteoporosis	0.000232	0.000659	CcSEcCtD
Temsirolimus—Diarrhoea—Alendronate—osteoporosis	0.000231	0.000658	CcSEcCtD
Temsirolimus—Asthenia—Calcitriol—osteoporosis	0.000231	0.000657	CcSEcCtD
Temsirolimus—Nervous system disorder—Zoledronate—osteoporosis	0.000231	0.000657	CcSEcCtD
Temsirolimus—Immune system disorder—Estradiol—osteoporosis	0.000231	0.000656	CcSEcCtD
Temsirolimus—Thrombocytopenia—Zoledronate—osteoporosis	0.00023	0.000656	CcSEcCtD
Temsirolimus—Mediastinal disorder—Estradiol—osteoporosis	0.00023	0.000655	CcSEcCtD
Temsirolimus—Dyspnoea—Pamidronate—osteoporosis	0.00023	0.000654	CcSEcCtD
Temsirolimus—Chills—Estradiol—osteoporosis	0.000229	0.000652	CcSEcCtD
Temsirolimus—Somnolence—Pamidronate—osteoporosis	0.000229	0.000652	CcSEcCtD
Temsirolimus—Skin disorder—Zoledronate—osteoporosis	0.000229	0.000651	CcSEcCtD
Temsirolimus—Pruritus—Calcitriol—osteoporosis	0.000228	0.000648	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000227	0.000647	CcSEcCtD
Temsirolimus—Diarrhoea—Raloxifene—osteoporosis	0.000227	0.000647	CcSEcCtD
Temsirolimus—Dizziness—Estropipate—osteoporosis	0.000227	0.000645	CcSEcCtD
Temsirolimus—Oedema—Conjugated Estrogens—osteoporosis	0.000227	0.000645	CcSEcCtD
Temsirolimus—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000227	0.000645	CcSEcCtD
Temsirolimus—Infection—Conjugated Estrogens—osteoporosis	0.000225	0.000641	CcSEcCtD
Temsirolimus—Diarrhoea—Ibandronate—osteoporosis	0.000225	0.00064	CcSEcCtD
Temsirolimus—Anorexia—Zoledronate—osteoporosis	0.000224	0.000638	CcSEcCtD
Temsirolimus—Decreased appetite—Pamidronate—osteoporosis	0.000224	0.000637	CcSEcCtD
Temsirolimus—Mental disorder—Estradiol—osteoporosis	0.000224	0.000636	CcSEcCtD
Temsirolimus—Dizziness—Alendronate—osteoporosis	0.000223	0.000636	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000222	0.000633	CcSEcCtD
Temsirolimus—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000222	0.000632	CcSEcCtD
Temsirolimus—Malnutrition—Estradiol—osteoporosis	0.000222	0.000632	CcSEcCtD
Temsirolimus—Erythema—Estradiol—osteoporosis	0.000222	0.000632	CcSEcCtD
Temsirolimus—Fatigue—Pamidronate—osteoporosis	0.000222	0.000632	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Risedronate—osteoporosis	0.000222	0.000631	CcSEcCtD
Temsirolimus—Pain—Pamidronate—osteoporosis	0.00022	0.000627	CcSEcCtD
Temsirolimus—Constipation—Pamidronate—osteoporosis	0.00022	0.000627	CcSEcCtD
Temsirolimus—Diarrhoea—Calcitriol—osteoporosis	0.00022	0.000627	CcSEcCtD
Temsirolimus—Skin disorder—Conjugated Estrogens—osteoporosis	0.00022	0.000626	CcSEcCtD
Temsirolimus—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00022	0.000625	CcSEcCtD
Temsirolimus—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00022	0.000625	CcSEcCtD
Temsirolimus—Dizziness—Raloxifene—osteoporosis	0.00022	0.000625	CcSEcCtD
Temsirolimus—Vomiting—Estropipate—osteoporosis	0.000218	0.000621	CcSEcCtD
Temsirolimus—Dysgeusia—Estradiol—osteoporosis	0.000218	0.000619	CcSEcCtD
Temsirolimus—Dizziness—Ibandronate—osteoporosis	0.000217	0.000619	CcSEcCtD
Temsirolimus—Rash—Estropipate—osteoporosis	0.000216	0.000615	CcSEcCtD
Temsirolimus—Dermatitis—Estropipate—osteoporosis	0.000216	0.000615	CcSEcCtD
Temsirolimus—Anorexia—Conjugated Estrogens—osteoporosis	0.000216	0.000615	CcSEcCtD
Temsirolimus—Back pain—Estradiol—osteoporosis	0.000215	0.000612	CcSEcCtD
Temsirolimus—Headache—Estropipate—osteoporosis	0.000215	0.000611	CcSEcCtD
Temsirolimus—Vomiting—Alendronate—osteoporosis	0.000215	0.000611	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000214	0.00061	CcSEcCtD
Temsirolimus—Abdominal pain—Risedronate—osteoporosis	0.000214	0.00061	CcSEcCtD
Temsirolimus—Body temperature increased—Risedronate—osteoporosis	0.000214	0.00061	CcSEcCtD
Temsirolimus—Rash—Alendronate—osteoporosis	0.000213	0.000606	CcSEcCtD
Temsirolimus—Insomnia—Zoledronate—osteoporosis	0.000213	0.000606	CcSEcCtD
Temsirolimus—Dermatitis—Alendronate—osteoporosis	0.000213	0.000606	CcSEcCtD
Temsirolimus—Headache—Alendronate—osteoporosis	0.000212	0.000602	CcSEcCtD
Temsirolimus—Vomiting—Raloxifene—osteoporosis	0.000211	0.000601	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Pamidronate—osteoporosis	0.000211	0.0006	CcSEcCtD
Temsirolimus—Dyspnoea—Zoledronate—osteoporosis	0.00021	0.000597	CcSEcCtD
Temsirolimus—Rash—Raloxifene—osteoporosis	0.000209	0.000596	CcSEcCtD
Temsirolimus—Dermatitis—Raloxifene—osteoporosis	0.000209	0.000596	CcSEcCtD
Temsirolimus—Somnolence—Zoledronate—osteoporosis	0.000209	0.000595	CcSEcCtD
Temsirolimus—Vomiting—Ibandronate—osteoporosis	0.000209	0.000595	CcSEcCtD
Temsirolimus—Headache—Raloxifene—osteoporosis	0.000208	0.000592	CcSEcCtD
Temsirolimus—Rash—Ibandronate—osteoporosis	0.000207	0.00059	CcSEcCtD
Temsirolimus—Dermatitis—Ibandronate—osteoporosis	0.000207	0.00059	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000206	0.000588	CcSEcCtD
Temsirolimus—Headache—Ibandronate—osteoporosis	0.000206	0.000586	CcSEcCtD
Temsirolimus—Insomnia—Conjugated Estrogens—osteoporosis	0.000205	0.000583	CcSEcCtD
Temsirolimus—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000205	0.000583	CcSEcCtD
Temsirolimus—Vomiting—Calcitriol—osteoporosis	0.000205	0.000583	CcSEcCtD
Temsirolimus—Decreased appetite—Zoledronate—osteoporosis	0.000205	0.000582	CcSEcCtD
Temsirolimus—Nausea—Estropipate—osteoporosis	0.000204	0.00058	CcSEcCtD
Temsirolimus—Body temperature increased—Pamidronate—osteoporosis	0.000204	0.00058	CcSEcCtD
Temsirolimus—Abdominal pain—Pamidronate—osteoporosis	0.000204	0.00058	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000203	0.000578	CcSEcCtD
Temsirolimus—Angioedema—Estradiol—osteoporosis	0.000203	0.000578	CcSEcCtD
Temsirolimus—Rash—Calcitriol—osteoporosis	0.000203	0.000578	CcSEcCtD
Temsirolimus—Fatigue—Zoledronate—osteoporosis	0.000203	0.000577	CcSEcCtD
Temsirolimus—Dermatitis—Calcitriol—osteoporosis	0.000203	0.000577	CcSEcCtD
Temsirolimus—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000202	0.000575	CcSEcCtD
Temsirolimus—Headache—Calcitriol—osteoporosis	0.000202	0.000574	CcSEcCtD
Temsirolimus—Somnolence—Conjugated Estrogens—osteoporosis	0.000201	0.000573	CcSEcCtD
Temsirolimus—Pain—Zoledronate—osteoporosis	0.000201	0.000573	CcSEcCtD
Temsirolimus—Constipation—Zoledronate—osteoporosis	0.000201	0.000573	CcSEcCtD
Temsirolimus—Nausea—Alendronate—osteoporosis	0.000201	0.000571	CcSEcCtD
Temsirolimus—Hypersensitivity—Risedronate—osteoporosis	0.0002	0.000568	CcSEcCtD
Temsirolimus—Asthenia—Ethinyl Estradiol—osteoporosis	0.000199	0.000568	CcSEcCtD
Temsirolimus—Nausea—Raloxifene—osteoporosis	0.000197	0.000562	CcSEcCtD
Temsirolimus—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000197	0.000561	CcSEcCtD
Temsirolimus—Pruritus—Ethinyl Estradiol—osteoporosis	0.000197	0.00056	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000196	0.000557	CcSEcCtD
Temsirolimus—Fatigue—Conjugated Estrogens—osteoporosis	0.000195	0.000556	CcSEcCtD
Temsirolimus—Nausea—Ibandronate—osteoporosis	0.000195	0.000556	CcSEcCtD
Temsirolimus—Asthenia—Risedronate—osteoporosis	0.000194	0.000553	CcSEcCtD
Temsirolimus—Cough—Estradiol—osteoporosis	0.000194	0.000552	CcSEcCtD
Temsirolimus—Pain—Conjugated Estrogens—osteoporosis	0.000194	0.000551	CcSEcCtD
Temsirolimus—Constipation—Conjugated Estrogens—osteoporosis	0.000194	0.000551	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Zoledronate—osteoporosis	0.000192	0.000548	CcSEcCtD
Temsirolimus—Hypertension—Estradiol—osteoporosis	0.000192	0.000546	CcSEcCtD
Temsirolimus—Pruritus—Risedronate—osteoporosis	0.000192	0.000546	CcSEcCtD
Temsirolimus—Nausea—Calcitriol—osteoporosis	0.000191	0.000544	CcSEcCtD
Temsirolimus—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00019	0.000541	CcSEcCtD
Temsirolimus—Hypersensitivity—Pamidronate—osteoporosis	0.00019	0.00054	CcSEcCtD
Temsirolimus—Arthralgia—Estradiol—osteoporosis	0.000189	0.000538	CcSEcCtD
Temsirolimus—Myalgia—Estradiol—osteoporosis	0.000189	0.000538	CcSEcCtD
Temsirolimus—Chest pain—Estradiol—osteoporosis	0.000189	0.000538	CcSEcCtD
Temsirolimus—Anxiety—Estradiol—osteoporosis	0.000189	0.000537	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000188	0.000535	CcSEcCtD
Temsirolimus—Body temperature increased—Zoledronate—osteoporosis	0.000186	0.000529	CcSEcCtD
Temsirolimus—Abdominal pain—Zoledronate—osteoporosis	0.000186	0.000529	CcSEcCtD
Temsirolimus—Diarrhoea—Risedronate—osteoporosis	0.000185	0.000528	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000185	0.000527	CcSEcCtD
Temsirolimus—Asthenia—Pamidronate—osteoporosis	0.000185	0.000526	CcSEcCtD
Temsirolimus—Dizziness—Ethinyl Estradiol—osteoporosis	0.000184	0.000523	CcSEcCtD
Temsirolimus—Pruritus—Pamidronate—osteoporosis	0.000182	0.000519	CcSEcCtD
Temsirolimus—Anaphylactic shock—Estradiol—osteoporosis	0.000181	0.000516	CcSEcCtD
Temsirolimus—Oedema—Estradiol—osteoporosis	0.000181	0.000516	CcSEcCtD
Temsirolimus—Infection—Estradiol—osteoporosis	0.00018	0.000513	CcSEcCtD
Temsirolimus—Dizziness—Risedronate—osteoporosis	0.000179	0.00051	CcSEcCtD
Temsirolimus—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000179	0.00051	CcSEcCtD
Temsirolimus—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000179	0.00051	CcSEcCtD
Temsirolimus—Nervous system disorder—Estradiol—osteoporosis	0.000178	0.000506	CcSEcCtD
Temsirolimus—Vomiting—Ethinyl Estradiol—osteoporosis	0.000177	0.000503	CcSEcCtD
Temsirolimus—Diarrhoea—Pamidronate—osteoporosis	0.000176	0.000502	CcSEcCtD
Temsirolimus—Skin disorder—Estradiol—osteoporosis	0.000176	0.000501	CcSEcCtD
Temsirolimus—Rash—Ethinyl Estradiol—osteoporosis	0.000175	0.000499	CcSEcCtD
Temsirolimus—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000175	0.000498	CcSEcCtD
Temsirolimus—Headache—Ethinyl Estradiol—osteoporosis	0.000174	0.000496	CcSEcCtD
Temsirolimus—Hypersensitivity—Zoledronate—osteoporosis	0.000173	0.000493	CcSEcCtD
Temsirolimus—Vomiting—Risedronate—osteoporosis	0.000172	0.00049	CcSEcCtD
Temsirolimus—Rash—Risedronate—osteoporosis	0.000171	0.000486	CcSEcCtD
Temsirolimus—Dermatitis—Risedronate—osteoporosis	0.000171	0.000486	CcSEcCtD
Temsirolimus—Dizziness—Pamidronate—osteoporosis	0.00017	0.000485	CcSEcCtD
Temsirolimus—Headache—Risedronate—osteoporosis	0.00017	0.000483	CcSEcCtD
Temsirolimus—Asthenia—Zoledronate—osteoporosis	0.000169	0.000481	CcSEcCtD
Temsirolimus—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000167	0.000475	CcSEcCtD
Temsirolimus—Pruritus—Zoledronate—osteoporosis	0.000166	0.000474	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000165	0.00047	CcSEcCtD
Temsirolimus—Nausea—Ethinyl Estradiol—osteoporosis	0.000165	0.00047	CcSEcCtD
Temsirolimus—Insomnia—Estradiol—osteoporosis	0.000164	0.000467	CcSEcCtD
Temsirolimus—Vomiting—Pamidronate—osteoporosis	0.000164	0.000466	CcSEcCtD
Temsirolimus—Asthenia—Conjugated Estrogens—osteoporosis	0.000163	0.000463	CcSEcCtD
Temsirolimus—Rash—Pamidronate—osteoporosis	0.000162	0.000462	CcSEcCtD
Temsirolimus—Dermatitis—Pamidronate—osteoporosis	0.000162	0.000462	CcSEcCtD
Temsirolimus—Dyspnoea—Estradiol—osteoporosis	0.000162	0.00046	CcSEcCtD
Temsirolimus—Headache—Pamidronate—osteoporosis	0.000161	0.000459	CcSEcCtD
Temsirolimus—Somnolence—Estradiol—osteoporosis	0.000161	0.000459	CcSEcCtD
Temsirolimus—Diarrhoea—Zoledronate—osteoporosis	0.000161	0.000458	CcSEcCtD
Temsirolimus—Nausea—Risedronate—osteoporosis	0.000161	0.000458	CcSEcCtD
Temsirolimus—Pruritus—Conjugated Estrogens—osteoporosis	0.00016	0.000456	CcSEcCtD
Temsirolimus—Decreased appetite—Estradiol—osteoporosis	0.000158	0.000449	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Estradiol—osteoporosis	0.000157	0.000446	CcSEcCtD
Temsirolimus—Fatigue—Estradiol—osteoporosis	0.000156	0.000445	CcSEcCtD
Temsirolimus—Dizziness—Zoledronate—osteoporosis	0.000156	0.000443	CcSEcCtD
Temsirolimus—Constipation—Estradiol—osteoporosis	0.000155	0.000441	CcSEcCtD
Temsirolimus—Pain—Estradiol—osteoporosis	0.000155	0.000441	CcSEcCtD
Temsirolimus—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000155	0.000441	CcSEcCtD
Temsirolimus—Nausea—Pamidronate—osteoporosis	0.000153	0.000436	CcSEcCtD
Temsirolimus—Dizziness—Conjugated Estrogens—osteoporosis	0.00015	0.000426	CcSEcCtD
Temsirolimus—Vomiting—Zoledronate—osteoporosis	0.00015	0.000426	CcSEcCtD
Temsirolimus—Rash—Zoledronate—osteoporosis	0.000148	0.000422	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Estradiol—osteoporosis	0.000148	0.000422	CcSEcCtD
Temsirolimus—Dermatitis—Zoledronate—osteoporosis	0.000148	0.000422	CcSEcCtD
Temsirolimus—Headache—Zoledronate—osteoporosis	0.000147	0.00042	CcSEcCtD
Temsirolimus—Vomiting—Conjugated Estrogens—osteoporosis	0.000144	0.00041	CcSEcCtD
Temsirolimus—Body temperature increased—Estradiol—osteoporosis	0.000143	0.000408	CcSEcCtD
Temsirolimus—Abdominal pain—Estradiol—osteoporosis	0.000143	0.000408	CcSEcCtD
Temsirolimus—Rash—Conjugated Estrogens—osteoporosis	0.000143	0.000407	CcSEcCtD
Temsirolimus—Dermatitis—Conjugated Estrogens—osteoporosis	0.000143	0.000406	CcSEcCtD
Temsirolimus—Headache—Conjugated Estrogens—osteoporosis	0.000142	0.000404	CcSEcCtD
Temsirolimus—Nausea—Zoledronate—osteoporosis	0.00014	0.000398	CcSEcCtD
Temsirolimus—Nausea—Conjugated Estrogens—osteoporosis	0.000135	0.000383	CcSEcCtD
Temsirolimus—Hypersensitivity—Estradiol—osteoporosis	0.000134	0.00038	CcSEcCtD
Temsirolimus—Asthenia—Estradiol—osteoporosis	0.00013	0.00037	CcSEcCtD
Temsirolimus—Pruritus—Estradiol—osteoporosis	0.000128	0.000365	CcSEcCtD
Temsirolimus—Diarrhoea—Estradiol—osteoporosis	0.000124	0.000353	CcSEcCtD
Temsirolimus—Dizziness—Estradiol—osteoporosis	0.00012	0.000341	CcSEcCtD
Temsirolimus—Vomiting—Estradiol—osteoporosis	0.000115	0.000328	CcSEcCtD
Temsirolimus—Rash—Estradiol—osteoporosis	0.000114	0.000325	CcSEcCtD
Temsirolimus—Dermatitis—Estradiol—osteoporosis	0.000114	0.000325	CcSEcCtD
Temsirolimus—Headache—Estradiol—osteoporosis	0.000114	0.000323	CcSEcCtD
Temsirolimus—Nausea—Estradiol—osteoporosis	0.000108	0.000307	CcSEcCtD
Temsirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.41e-05	0.000679	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—WNT1—osteoporosis	8.34e-05	0.000673	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—osteoporosis	8.19e-05	0.000661	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—osteoporosis	8.13e-05	0.000656	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL1B—osteoporosis	8.13e-05	0.000656	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGA—osteoporosis	8.11e-05	0.000654	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TPI1—osteoporosis	7.99e-05	0.000645	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—POMC—osteoporosis	7.79e-05	0.000629	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.78e-05	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RAP1A—osteoporosis	7.78e-05	0.000628	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MGLL—osteoporosis	7.74e-05	0.000625	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTSK—osteoporosis	7.71e-05	0.000622	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFATC1—osteoporosis	7.59e-05	0.000612	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LRP5—osteoporosis	7.55e-05	0.00061	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTHLH—osteoporosis	7.54e-05	0.000608	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—BMP2—osteoporosis	7.54e-05	0.000608	CbGpPWpGaD
Temsirolimus—MTOR—Disease—P4HB—osteoporosis	7.51e-05	0.000606	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CA2—osteoporosis	7.5e-05	0.000605	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—OXCT1—osteoporosis	7.5e-05	0.000605	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGB—osteoporosis	7.38e-05	0.000595	CbGpPWpGaD
Temsirolimus—MTOR—Disease—GAPDH—osteoporosis	7.37e-05	0.000595	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—FDPS—osteoporosis	7.35e-05	0.000593	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PKM—osteoporosis	7.35e-05	0.000593	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MGLL—osteoporosis	7.31e-05	0.00059	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LRP6—osteoporosis	7.23e-05	0.000583	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PSMA2—osteoporosis	7.12e-05	0.000575	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PSMA5—osteoporosis	7.12e-05	0.000575	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AGER—osteoporosis	7.08e-05	0.000571	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—ADCY5—osteoporosis	7.05e-05	0.000569	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NFATC1—osteoporosis	7.01e-05	0.000565	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPD2—osteoporosis	6.97e-05	0.000562	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PGLS—osteoporosis	6.97e-05	0.000562	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—osteoporosis	6.96e-05	0.000562	CbGpPWpGaD
Temsirolimus—MTOR—Disease—DKK1—osteoporosis	6.95e-05	0.000561	CbGpPWpGaD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.82e-05	0.00055	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ADCY5—osteoporosis	6.74e-05	0.000544	CbGpPWpGaD
Temsirolimus—MTOR—Disease—WNT1—osteoporosis	6.7e-05	0.00054	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—osteoporosis	6.66e-05	0.000537	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CALCA—osteoporosis	6.64e-05	0.000536	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—osteoporosis	6.55e-05	0.000529	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGA—osteoporosis	6.51e-05	0.000526	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ATIC—osteoporosis	6.37e-05	0.000514	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PNP—osteoporosis	6.37e-05	0.000514	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—osteoporosis	6.32e-05	0.00051	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—osteoporosis	6.26e-05	0.000505	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—osteoporosis	6.23e-05	0.000502	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—IDH2—osteoporosis	6.21e-05	0.000501	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MTHFR—osteoporosis	6.2e-05	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—osteoporosis	6.2e-05	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PSMA5—osteoporosis	6.2e-05	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PSMA2—osteoporosis	6.2e-05	0.0005	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IRS2—osteoporosis	6.17e-05	0.000498	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—osteoporosis	6.17e-05	0.000498	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TLN1—osteoporosis	6.1e-05	0.000492	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	6.03e-05	0.000486	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KL—osteoporosis	6.03e-05	0.000486	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	6.01e-05	0.000485	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.95e-05	0.00048	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—IRS2—osteoporosis	5.92e-05	0.000478	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—osteoporosis	5.9e-05	0.000476	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IRS2—osteoporosis	5.9e-05	0.000476	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP27A1—osteoporosis	5.84e-05	0.000471	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ENO1—osteoporosis	5.81e-05	0.000469	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	5.8e-05	0.000468	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—osteoporosis	5.8e-05	0.000468	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—osteoporosis	5.8e-05	0.000468	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—osteoporosis	5.75e-05	0.000464	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PSMA2—osteoporosis	5.72e-05	0.000462	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PSMA5—osteoporosis	5.72e-05	0.000462	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—osteoporosis	5.7e-05	0.00046	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ACP5—osteoporosis	5.68e-05	0.000458	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—osteoporosis	5.67e-05	0.000458	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PKM—osteoporosis	5.55e-05	0.000448	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—FDPS—osteoporosis	5.55e-05	0.000448	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—POMC—osteoporosis	5.54e-05	0.000447	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—OXCT1—osteoporosis	5.42e-05	0.000437	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CA2—osteoporosis	5.42e-05	0.000437	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IRS1—osteoporosis	5.39e-05	0.000435	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CALCA—osteoporosis	5.33e-05	0.00043	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—TPI1—osteoporosis	5.28e-05	0.000426	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MGLL—osteoporosis	5.28e-05	0.000426	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—P4HB—osteoporosis	5.26e-05	0.000425	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PGLS—osteoporosis	5.26e-05	0.000424	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPD2—osteoporosis	5.26e-05	0.000424	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KL—osteoporosis	5.24e-05	0.000423	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—FDPS—osteoporosis	5.23e-05	0.000422	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PKM—osteoporosis	5.23e-05	0.000422	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	5.2e-05	0.00042	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—IRS1—osteoporosis	5.17e-05	0.000417	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IRS1—osteoporosis	5.15e-05	0.000416	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	5.14e-05	0.000415	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTH—osteoporosis	5.12e-05	0.000413	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6R—osteoporosis	5.06e-05	0.000408	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RAP1A—osteoporosis	5.03e-05	0.000406	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CNR2—osteoporosis	4.99e-05	0.000402	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—P4HB—osteoporosis	4.97e-05	0.000401	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PGLS—osteoporosis	4.95e-05	0.0004	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPD2—osteoporosis	4.95e-05	0.0004	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFATC1—osteoporosis	4.91e-05	0.000396	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GAPDH—osteoporosis	4.87e-05	0.000393	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—DKK1—osteoporosis	4.87e-05	0.000393	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KL—osteoporosis	4.84e-05	0.000391	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6R—osteoporosis	4.84e-05	0.00039	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ATIC—osteoporosis	4.81e-05	0.000388	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PNP—osteoporosis	4.81e-05	0.000388	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—RAP1A—osteoporosis	4.75e-05	0.000383	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ADCY5—osteoporosis	4.72e-05	0.000381	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—WNT1—osteoporosis	4.69e-05	0.000378	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SPP1—osteoporosis	4.57e-05	0.000369	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGA—osteoporosis	4.56e-05	0.000368	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PNP—osteoporosis	4.53e-05	0.000366	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ATIC—osteoporosis	4.53e-05	0.000366	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—IDH2—osteoporosis	4.49e-05	0.000362	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTHLH—osteoporosis	4.24e-05	0.000342	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BMP2—osteoporosis	4.24e-05	0.000342	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP27A1—osteoporosis	4.22e-05	0.000341	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—osteoporosis	4.21e-05	0.00034	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGB—osteoporosis	4.15e-05	0.000335	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IRS2—osteoporosis	4.13e-05	0.000333	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AGER—osteoporosis	4.12e-05	0.000333	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ADCY5—osteoporosis	4.11e-05	0.000331	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ACP5—osteoporosis	4.11e-05	0.000331	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—OXCT1—osteoporosis	4.09e-05	0.00033	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CA2—osteoporosis	4.09e-05	0.00033	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—LEP—osteoporosis	4.04e-05	0.000326	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PSMA2—osteoporosis	4.01e-05	0.000323	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PSMA5—osteoporosis	4.01e-05	0.000323	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MGLL—osteoporosis	3.98e-05	0.000322	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—osteoporosis	3.95e-05	0.000319	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ESR1—osteoporosis	3.86e-05	0.000311	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CA2—osteoporosis	3.85e-05	0.000311	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—OXCT1—osteoporosis	3.85e-05	0.000311	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ENO1—osteoporosis	3.84e-05	0.00031	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—TPI1—osteoporosis	3.82e-05	0.000308	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ADCY5—osteoporosis	3.79e-05	0.000306	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PSMA5—osteoporosis	3.78e-05	0.000305	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PSMA2—osteoporosis	3.78e-05	0.000305	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MGLL—osteoporosis	3.75e-05	0.000303	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CALCA—osteoporosis	3.73e-05	0.000301	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—POMC—osteoporosis	3.62e-05	0.000292	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IRS1—osteoporosis	3.61e-05	0.000291	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRS2—osteoporosis	3.59e-05	0.00029	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—P4HB—osteoporosis	3.59e-05	0.00029	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GAPDH—osteoporosis	3.52e-05	0.000284	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MTHFR—osteoporosis	3.49e-05	0.000281	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—POMC—osteoporosis	3.47e-05	0.00028	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—RAP1A—osteoporosis	3.43e-05	0.000277	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—FDPS—osteoporosis	3.42e-05	0.000276	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PKM—osteoporosis	3.42e-05	0.000276	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KL—osteoporosis	3.39e-05	0.000274	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—IDH2—osteoporosis	3.39e-05	0.000273	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6R—osteoporosis	3.39e-05	0.000273	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF1—osteoporosis	3.34e-05	0.00027	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IRS2—osteoporosis	3.32e-05	0.000268	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PGLS—osteoporosis	3.24e-05	0.000261	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPD2—osteoporosis	3.24e-05	0.000261	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—IDH2—osteoporosis	3.19e-05	0.000258	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP27A1—osteoporosis	3.19e-05	0.000257	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IRS1—osteoporosis	3.14e-05	0.000253	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	3.13e-05	0.000252	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	3.12e-05	0.000252	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ACP5—osteoporosis	3.1e-05	0.00025	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP19A1—osteoporosis	3.07e-05	0.000248	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP27A1—osteoporosis	3e-05	0.000242	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ATIC—osteoporosis	2.96e-05	0.000239	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PNP—osteoporosis	2.96e-05	0.000239	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6R—osteoporosis	2.95e-05	0.000238	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ACP5—osteoporosis	2.92e-05	0.000236	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.92e-05	0.000236	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.91e-05	0.000235	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IRS1—osteoporosis	2.9e-05	0.000234	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—TPI1—osteoporosis	2.88e-05	0.000232	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—osteoporosis	2.87e-05	0.000231	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—osteoporosis	2.86e-05	0.000231	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ENO1—osteoporosis	2.77e-05	0.000224	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PSMA2—osteoporosis	2.73e-05	0.000221	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PSMA5—osteoporosis	2.73e-05	0.000221	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6R—osteoporosis	2.72e-05	0.00022	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—TPI1—osteoporosis	2.71e-05	0.000219	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—P4HB—osteoporosis	2.71e-05	0.000219	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GAPDH—osteoporosis	2.66e-05	0.000215	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ADCY5—osteoporosis	2.66e-05	0.000214	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—RAP1A—osteoporosis	2.59e-05	0.000209	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPP1—osteoporosis	2.57e-05	0.000207	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—P4HB—osteoporosis	2.55e-05	0.000206	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CA2—osteoporosis	2.52e-05	0.000203	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—OXCT1—osteoporosis	2.52e-05	0.000203	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ADCY5—osteoporosis	2.51e-05	0.000202	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GAPDH—osteoporosis	2.51e-05	0.000202	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GPX1—osteoporosis	2.5e-05	0.000202	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MGLL—osteoporosis	2.45e-05	0.000198	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—RAP1A—osteoporosis	2.44e-05	0.000197	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IRS2—osteoporosis	2.32e-05	0.000187	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—osteoporosis	2.31e-05	0.000186	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LEP—osteoporosis	2.27e-05	0.000183	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—osteoporosis	2.25e-05	0.000182	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—osteoporosis	2.24e-05	0.000181	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP19A1—osteoporosis	2.22e-05	0.000179	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ESR1—osteoporosis	2.17e-05	0.000175	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—osteoporosis	2.16e-05	0.000174	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ENO1—osteoporosis	2.09e-05	0.000169	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—IDH2—osteoporosis	2.09e-05	0.000168	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PSMA2—osteoporosis	2.06e-05	0.000166	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PSMA5—osteoporosis	2.06e-05	0.000166	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IRS1—osteoporosis	2.03e-05	0.000164	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—osteoporosis	2.01e-05	0.000162	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—osteoporosis	2e-05	0.000162	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ENO1—osteoporosis	1.97e-05	0.000159	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.96e-05	0.000158	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—POMC—osteoporosis	1.95e-05	0.000158	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PSMA5—osteoporosis	1.94e-05	0.000157	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PSMA2—osteoporosis	1.94e-05	0.000157	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ACP5—osteoporosis	1.91e-05	0.000154	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6R—osteoporosis	1.91e-05	0.000154	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1—osteoporosis	1.88e-05	0.000152	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—POMC—osteoporosis	1.84e-05	0.000149	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ADCY5—osteoporosis	1.81e-05	0.000146	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GPX1—osteoporosis	1.81e-05	0.000146	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—TPI1—osteoporosis	1.77e-05	0.000143	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP19A1—osteoporosis	1.67e-05	0.000135	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—P4HB—osteoporosis	1.67e-05	0.000135	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—osteoporosis	1.67e-05	0.000134	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GAPDH—osteoporosis	1.64e-05	0.000132	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—osteoporosis	1.61e-05	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—osteoporosis	1.61e-05	0.00013	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—RAP1A—osteoporosis	1.6e-05	0.000129	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.58e-05	0.000127	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—osteoporosis	1.51e-05	0.000122	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ADCY5—osteoporosis	1.37e-05	0.00011	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GPX1—osteoporosis	1.36e-05	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—POMC—osteoporosis	1.33e-05	0.000108	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—osteoporosis	1.31e-05	0.000106	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ENO1—osteoporosis	1.29e-05	0.000104	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ADCY5—osteoporosis	1.29e-05	0.000104	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GPX1—osteoporosis	1.28e-05	0.000104	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PSMA2—osteoporosis	1.27e-05	0.000103	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PSMA5—osteoporosis	1.27e-05	0.000103	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—osteoporosis	1.26e-05	0.000101	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—osteoporosis	1.21e-05	9.78e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—osteoporosis	1.18e-05	9.56e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—osteoporosis	1.13e-05	9.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—osteoporosis	1.13e-05	9.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.03e-05	8.32e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—POMC—osteoporosis	1.01e-05	8.12e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—POMC—osteoporosis	9.48e-06	7.65e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—osteoporosis	8.49e-06	6.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ADCY5—osteoporosis	8.42e-06	6.8e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GPX1—osteoporosis	8.39e-06	6.77e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—osteoporosis	7.75e-06	6.25e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—POMC—osteoporosis	6.2e-06	5e-05	CbGpPWpGaD
